To Evaluate the Efficacy and Safety in Patients With Dyslipidemia and Hypertension

A Multi-center, Randomized, Double-blind, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0101+C2101 in Patients With Dyslipidemia and Hypertension.

A Multi-center, Randomized, Double-blind, Parallel, phase III Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0101+C2101 in Patients with Dyslipidemia and Hypertension.

Multicenter, randomized, double-blind, parallel-design, phase III clinical study

Inclusion Criteria:

• Patients with hypertension and dyslipidemia

Exclusion Criteria:

• The subject not meet the specified msBP and LDL-C level